4//SEC Filing
Latham John A 4
Accession 0001209191-19-008581
CIK 0001423824other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:47 PM ET
Size
7.5 KB
Accession
0001209191-19-008581
Insider Transaction Report
Form 4
Latham John A
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-06+160,000→ 160,000 totalExercise: $14.00Exp: 2029-02-05→ Common Stock (160,000 underlying) - Award
Common Stock
2018-11-30$9.35/sh+487$4,553→ 244,180 total
Footnotes (2)
- [F1]The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2018 in a transaction exempt under Rule 16b-3(c).
- [F2]The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 1, 2019 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
Documents
Issuer
ALDER BIOPHARMACEUTICALS INC
CIK 0001423824
Entity typeother
Related Parties
1- filerCIK 0001604874
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:47 PM ET
- Size
- 7.5 KB